Herein, we discuss the availability of hCG, FSH, and LH for men seeking treatment for symptomatic hypogonadism and infertility, as well as the lack of hormonal therapy available from previously utilized 503b compounding pharmacies. Here, BRD2 is linked to hypogonadism.